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The regulation of hepatic glucose metabolism is im-
portant in glucose homeostasis, and liver glucokinase
(LGK) plays a central role in this process. Hepatic glu-
cokinase expression is known to be regulated by insulin.
Recently it has been suggested that sterol regulatory
element binding protein-1c (SREBP-1c) mediates the ac-
tion of insulin on LGK transcription; however, the pre-
cise mechanism is not, to date, well known. In the pres-
ent study, we identified two functional SREBP-1c
response elements, SREa and SREb, in the rat LGK pro-
moter. SREBP-1c could bind to these SREs and activate
the LGK promoter, and insulin activated the LGK pro-
moter in Alexander cells. The physical interaction be-
tween the protein and SREs of the LGK promoter in vivo
was also confirmed. Insulin selectively increased
SREBP-1c and LGK expression in primary hepatocytes.
Adenoviral expression of SREBP-1c stimulated LGK ex-
pression, and the dominant negative mutant of
SREBP-1c blocked the increased gene expression of
LGK by insulin and SREBP-1c. A chromatin immunopre-
cipitation assay using primary hepatocytes showed in-
creased binding of SREBP-1 to SREs of the LGK pro-
moter by insulin.
Liver is important for glucose and lipid metabolism, and
hepatic glucose and lipid metabolism are known to be mainly
regulated by insulin. The typical action of insulin in liver is to
increase glycolysis, glycogenesis, and lipogenesis. When glu-
cose is delivered to the liver in large quantities it is converted
to glycogen and stored. If the hepatic glycogen stores are re-
pleted, glucose enters the glycolysis pathway to produce pyru-
vate for de novo lipogenesis, and the lipid is exported as very
low density lipoprotein and stored as triacylglycerol in adipose
tissue. Thus, the regulation of hepatic glucose metabolism is
important in glucose homeostasis.
Glucose is phosphorylated by glucokinase (GK)1 (ATP: D-
hexose 6-phosphotransferase; EC 2.7.1.1) to produce glucose-6-
phosphate, which enters the glycolysis and glycogenesis path-
way (1). Because the Km of GK is considerably higher than that
of normal blood concentrations and because GK is not subjected
to allosteric regulation by the product, the rate of glucose
phosphorylation is proportional to the blood glucose level.
Therefore, GK is thought to be essential for the liver in sensing
glucose and maintaining the metabolic function (2, 3).
GK is mainly expressed in liver, pancreatic  cells, and
neuroendocrine cells of brain and gut. Two alternate promoters
regulate the tissue-specific expression of GK in liver and pan-
creatic  cells (4). The upstream promoter regulates  cell-
specific GK expression, and the downstream promoter controls
liver-specific GK (LGK) expression. In the liver, GK expression
is regulated in response to fasting and refeeding (5), with
insulin and glucagon serving as the mediators of this response.
Hepatic GK expression is reduced in the diabetic animal mod-
els with insulin deficiency and insulin resistance (6, 7). Insulin
stimulates GK expression in primary hepatocytes regardless of
glucose concentration, and glucagon inhibits GK expression (8,
9). These results indicate that insulin is a major activator of GK
transcription. However, the cis-element in the LGK promoter
that is responsible for insulin responsiveness has not yet been
identified. Besides transcriptional regulation, hepatic GK ac-
tivity can be regulated by the GK regulatory protein. At low
glucose concentrations, the GK regulatory protein is associated
with GK in the nucleus (10). Acute glucose challenge induces
dissociation of the GK-GK regulatory protein complex, and GK
is then translocated into cytoplasm, resulting in increased GK
activity (11, 12).
Sterol regulatory element-binding protein-1c (SREBP-1c),
also known as adipocyte determination and differentiation de-
pendent factor 1 (ADD1), is a member of the SREBP family
that regulates the transcription of genes involved in cholesterol
and fatty acid synthesis (13, 14). SREBPs are synthesized in a
precursor form bound to the endoplasmic reticulum and the
nuclear membrane. After proteolytic cleavage, mature SREBPs
enter the nucleus and activate the transcription of the target
genes by binding to sterol response element (SRE) or E-box-like
sequences. Three isoforms of SREBPs from two genes have
been identified. SREBP-1a and 1c are encoded from a single
gene but are different in their first exon due to alternative
usage of the promoter. Because two isoforms of SREBP-1 have
the same DNA binding domain, they recognize the same DNA
element. However, transcriptional activity of SREBP-1a is
stronger than that of SREBP-1c, because SREBP-1a has a
longer acidic transactivation domain (15). SREBP-1a is a po-
tent activator of all SREBP-responsive genes, whereas the
roles of SREBP-1c and SREBP-2 are more restricted in that
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SREBP-1c preferentially activates genes required for fatty acid
synthesis, and SREBP-2 activates genes for cholesterol synthe-
sis. Among three isoforms of SREBPs, SREBP-1c is mainly
expressed in liver and is regulated by nutritional status. Re-
cently, SREBP-1c was suggested to be a transcription factor
that mediates the action of insulin on GK transcription in liver
(23, 24). However, the mechanism used by SREBP-1c to induce
hepatic GK expression in response to insulin is not well
characterized.
Here, we identify SREs in the rat LGK promoter and present
evidence that insulin increases the binding of SREBP-1c on the
LGK promoter resulting in the increase of the LGK transcrip-
tion. These results indicate that SREBP-1c is a transcription
factor mediating the effects of insulin on the regulation of LGK
gene expression.
EXPERIMENTAL PROCEDURES
Plasmids—The luciferase reporter construct under the control of the
rat LGK promoter pRGL-1448 was described earlier (16). pRGL-593,
pRGL-238, pRGL-161, pRGL-76, pRGL4, and pRGL55 were con-
structed by amplifying the rat LGK promoter regions of 593/127,
238/127, 161/127, 76/127, 4/127, and 55/127 and sub-
cloning them into pGL3 basic vector, respectively. pRGL-1448ma,
pRGL-1448mb, and pRGL-1448mab were produced by introducing a
substitution mutation into pRGL-1448 using the QuikChange site-
directed mutagenesis kit (Stratagene, La Jolla, CA). The sequences of
all constructs were confirmed by DNA sequencing. The SRE-truncated
mutant pRGLab, the 210/-167 region of which was truncated from
pRGL-1448, was constructed by PCR using a SRE-truncation primer
(sense, 5-TTCTTTAACCAGTCTCTCTCCACAGCAAGT-3; antisense,
5-ACTTGCTGTGGAGAGAGACTGGTTAAAGAA-3). The expression
plasmid of SREBP-2 (pCS2) and the preparation of recombinant
SREBP-1 were described previously (17). Expression plasmids of
SREBP-1c and the dominant negative mutant of SREBP-1c (SREBP-
1cDN) were a kind gift from Drs. B. M. Spiegelman and J. B. Kim (18).
We subcloned SREBP-1c into pcDNA3 for experimental purposes.
Animals and Diet—Male Sprague-Dawley rats (150–200 g) were
used for the experiments. Rats were fasted for 24 h and refed a fat-free
high carbohydrate diet containing 82% (w/w) carbohydrates (74%
starch, 8% sucrose), 18% (w/w) casein, 1% vitamin mix, and 4% (w/w)
mineral mix. All components for the diet were purchased from Harlan
Teklad Co. (Madison, WI).
Cell Culture and Transient Transfection Assay—Alexander cells
(American Type Culture Collection number CRL-8024) were cultured in
Dulbecco’s modified Eagle’s medium (DMEM) (Invitrogen) supple-
mented with 10% (v/v) fetal bovine serum, 100 units/ml penicillin, and
100 g/ml streptomycin. Transient transfection and luciferase assays
were performed as described previously (19). Briefly, Alexander cells
were plated at a density of 2  105 cells/35-mm dish. On the following
day, 500 ng of luciferase reporter plasmid and 50 ng of overexpression
plasmid were transfected using LipofectAMINE Plus reagent (Invitro-
gen). To transfect a constant amount of DNA, sample DNAs were
supplemented with control vector pcDNA3. Protein concentration was
determined by the method of Bradford. Luciferase activities were nor-
malized by protein concentration to adjust transfection efficiency. Nor-
malized luciferase activities were shown as mean  S.D. of three
independent experiments in triplicate and were expressed as fold in-
crease relative to the basal activity of the reporters in the absence of
overexpression vectors.
Isolation of Total RNA, Northern Blot Analysis, and Reverse Transcrip-
tion PCR—Total RNA was extracted from liver and primary hepatocytes
using TRIzol reagent (Invitrogen) according to the manufacturer’s proto-
col (19). Twenty micrograms of total RNA was separated on 1% agarose
gels containing 0.66 M formaldehyde. After electrophoresis, RNA was
transferred to a nylon membrane by capillary transfer in 20 SSC and
UV-crosslinked. The 500-bp fragment representing exon 2 to exon 4 of the
rat GK gene, the 500-bp fragment of exon 2 to exon 4 of the rat SREBP-1
gene, and the 500-bp fragment of exon 2 to exon 4 of the rat SREBP-2 gene
were labeled with [-32P]dCTP using the Rediprime labeling kit (Amer-
sham Biosciences) and used as cDNA probes. The membrane was hybrid-
ized with 32P-labeled cDNA probes in Rapid-hyb buffer (Amersham Bio-
sciences) at 65 °C for 4 h. After hybridization, the membrane was washed
with 2 SSC 0.1% SDS followed by 0.2 SSC 0.1% SDS and exposed to
x-ray film at 70 °C with an intensifying screen.
For reverse transcription PCR, first strand cDNA was synthesized
from 4 g of total RNA in a 20-l volume using random hexamer and
Superscript II reverse transcriptase (Invitrogen). One microliter of the
reverse transcription reaction mixture was amplified with primers spe-
cific for rat LGK and -actin in a total volume of 50 l. Linearity of the
PCR was tested by amplifying 100 ng of total RNA in the amplification
cycles between 20 and 50. According to the amplification profile,
samples were amplified for 30 cycles using the parameters 92 °C for
30 s, 55 °C for 30 s, and 72 °C for 30 s. -actin was used as an internal
control for the quality and quantity of RNA. The identity of PCR pro-
ducts were subjected to electrophoresis on 1.5% agarose gel, and the
quantities of PCR products were analyzed by Molecular Analyst II
(Bio-Rad). The PCR product was confirmed by DNA sequencing.
Primers used in PCR were as follows: LGK-sense, 5-CAGACAGTCC-
TCACCTGCAA-3; LGK-antisense, 5-TGACCAGCATCACTCTGAAG-
3; SREBP-1a-sense, 5-ACACAGCGGTTTTGAACGACATC-3; SREB-
P-1a-antisense, 5-ACGGACGGGTACATCTTTACAG-3; SREBP-1c-
sense, 5-GGAGCCATGGATTGCACATT-3; SREBP-1c-antisense, 5-A-
GGAAGGCTTCCAGAGAGGA-3; -actin-sense, 5-TTGTAACCAACT-
GGGACGATATGG-3; and -actin-antisense, 5-CGACCAGA-
GGCATACAGGGACAAC-3.
DNase I Footprinting Assay—A DNase footprinting assay was per-
formed as described previously (20). DNA fragments covering from
320 to 69 of the LGK gene were labeled in sense strand and purified
as follows. The promoter region was amplified by PCR, and the result-
ing fragments were subcloned into the KpnI and EcoRI sites of the
pBluescript SK vector. The promoter fragments were isolated by
double digestion with KpnI and EcoRI to obtain 5-overhanging ends
and 3-overhanging ends. The fragments were labeled using a Klenow
fragment and [-32P]dATP and then purified from PAGE. DNA protein
binding reactions were performed using 50,000 cpm (1 ng) of probe per
reaction in a solution containing 10 mM HEPES, pH 7.9, 60 mM KCl, 7%
glycerol, 1 mM EDTA, 1 mM dithiothreitol, 2 g of poly(dI-dC), and the
indicated amount of purified recombinant SREBP-1. After a 20-min
incubation on ice, 5 l of DNase I freshly diluted in a solution contain-
ing 10 mM HEPES, pH 7.9, 60 mM KCl, 25 mM MgCl2, 5 mM CaCl2, and
7% glycerol was added to the reaction and kept at room temperature for
2 min. Dilution folds of DNase I were ranged from 1:200 to 1:2000 of
stock (10 units/l), depending on the amount of protein in the reaction.
Digestion reactions were stopped by adding 80 l of a stop solution
containing 20 mM Tris-Cl, pH 8, 20 mM EDTA, 250 mM NaCl, 0.5% SDS,
4 g of yeast tRNA, and 10 g of proteinase K. The samples were
resolved in 6% polyacrylamide and 7 M urea sequencing gel. The pro-
tected regions were mapped with reference to the migration of Maxam-
Gilbert sequencing products.
Electrophoretic Mobility Shift Assay (EMSA)—The oligonucleotide
probes P-216/-187 (for SREa), P-216/-187ma, P-188/-159 (for SREb), and
P-188/-159mb were labeled as described previously (19). Ten picomoles
of single-stranded sense oligonucleotide were labeled with 32P using T4
polynucleotide kinase (TaKaRa, Shiga, Japan) and annealed with a 5 M
excess of antisense oligonucleotide. 32P-labeled, double-stranded oligo-
nucleotides were purified with Sephadex G50 (Amersham Biosciences)
spin columns. P-225/-150, P-225/-150ma, P-225/-150mb, and P-225/-
150mab were generated by PCR using pRGL-1448, pRGL-1448ma,
pRGL-1448mb, and pRGL-1448mab as templates. 32P-labeled sense
oligonucleotides (5-TTCTTTAACCAGTCTGAAGG-3) and unlabeled
antisense oligonucleotides (5-GGACTTGCTGTGGAGAGGTT-3) were
used to amplify the probes. The labeled probes were purified by PAGE.
50,000 cpm (0.02 pmol) of probes were incubated with a recombinant
SREBP-1 protein for 20 min on ice in a buffer containing 10 mM HEPES
(pH 7.9), 60 mM KCl, 10% glycerol (v/v), and 1 mM dithiothreitol. One g
of poly(dI-dC) was added to each reaction to suppress nonspecific bind-
ing. For competition assays, excessive unlabeled oligonucleotides were
added to the reaction mixture. Two microliters of anti-SREBP-1 serum
was added to the reaction for a supershift assay. The protein-DNA
complexes were resolved from free probe by PAGE at 4 °C on a 4%
polyacrylamide gel in 0.5  Tris borate-EDTA buffer. The dried gels
were exposed to x-ray film at 70 °C with an intensifying screen.
Chromatin Immunoprecipitation (ChIP) Assay—Male Sprague-Daw-
ley rats (150 g) had free access to Purina chow and were divided into
fasting and refeeding groups. The fasting group fasted for 24 h. The
refeeding group had free access to high carbohydrate diet for 24 h after
fasting. The liver was perfused with serum-free DMEM for 5 min and
cross-linked with 5% formaldehyde in serum-free DMEM for 5 min. The
livers were homogenized, pelleted by centrifugation at 2000 rpm for 4
min at 4 °C, and resuspended in lysis buffer (1% SDS, 10 mM EDTA,
and 50 mM Tris-HCl, pH 8). The lysate was sonicated on ice for 3 min
with a 2.5 mm in diameter sonicator tip at 30% amplitude and a 0.5
cycle (UP400S; Dr. Hielscher GmbH, Teltow, Germany) and sheared to
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100–600 bp. To provide a positive control (input) for each condition, one
undiluted aliquot was retained for further processing in parallel with
all other samples at the reversal of the cross-linking step. To reduce
nonspecific background, each chromatin sample (1 ml) was precleared
using 60 l of protein A/G-agarose (Santa Cruz Biotechnology, Santa
Cruz, CA), supplemented with 200 g/ml sonicated salmon sperm DNA
(Stratagene), and the beads were pelleted. Chromatin complexes in the
supernatant were immunoprecipitated overnight at 4 °C using 30 g of
anti-SREBP-1 serum or preimmune serum or without serum. Immune
complexes were collected with 60 l of protein A/G-agarose and
200g/ml salmon sperm DNA. Chromatin complexes were eluted from
the beads and used for subsequent PCR analysis. LGK promoter-spe-
cific primers were 5-ATCCCACGAGGTACCCCCACTATTC-3 (sense)
and 5-GACTTGCTGTGGAGAGGTTA-3 (antisense).
Preparation of Recombinant Adenovirus—The cDNA encoding
SREBP-1c or SREBP-1cDN was cloned into the pAd-YC2 shuttle vector,
which has the cytomegalovirus promoter and multiple cloning sites, in-
cluding the bGHp(A) sequence (21). For homologous recombination, a
shuttle vector, pAd-YC2 (5 g), and a rescue vector, pJM17 (5 g), were
cotransfected into 293 cells, which had been cultured in a 24-well plate the
day before transfection. After 12–15 days, recombinants were screened by
PCR using upstream primers derived from the cytomegalovirus promoter
and downstream primers from the bGHp(A) sequence. Then, the recom-
binants were amplified in 293 cells and purified and isolated using CsCl2
(Sigma). The preparations were collected and desalted, and titers were
determined by the measurement of plaque counts.
Isolation of Primary Hepatocytes and Treatment of Recombinant
Adenovirus—Primary hepatocytes were isolated from normal Sprague-
Dawley rats (150 g) as described previously (22). The primary hepa-
tocytes were incubated for 2 h with an adenovirus containing DMEM at
a titer of 15 plaque-forming units per cell for 2 h at 37 °C. Then, culture
medium was replaced by DMEM supplemented with 10% fetal calf
serum. The infected cells were harvested for RNA isolation 24 h after
viral infection.
Statistical Analysis—All transfection studies were performed in trip-
licates and repeated 3–5 times. The data were represented as mean 
S.D. Statistical analysis was carried out using Microsoft Excel (Mi-
crosoft, Redmond, WA).
RESULTS
SREBP-1c Activates LGK Promoter—To determine the re-
sponse of the LGK promoter to SREBPs, a luciferase reporter
construct under the control of the LGK promoter pRGL-1448,
which contained the 1448/127 region of the rat LGK gene,
was prepared and transfected into Alexander cells with or with-
out expression of SREBPs. As shown in Fig. 1, SREBP-1c acti-
vated the LGK promoter, whereas SREBP-2 did not. We also
observed that SREBP-1a activated the promoter construct (data
not shown). This result suggested the presence of SRE in the
LGK promoter and the preference of the SRE to SREBP-1, which
was observed in many promoters of many lipogenic genes.
Localization of SRE in the LGK Promoter—To localize the
region responsible for the activation by SREBP-1, we prepared
5 deletion constructs and tested their responsiveness to
SREBP-1c in Alexander cells. As shown in Fig. 2A, pRGL-1448,
pRGL-593, and pRGL-238 were activated by SREBP-1c. But
pRGL-161 was slightly activated by SREBP-1c. This sight ac-
tivation did not disappear even in the reporter without pro-
moter. This marginal activation of reporter without promoter
might be due to the presence of an E-box in front of the multiple
cloning site of the pGL3basic plasmid. Thus, we assumed that
238/161 region was necessary for the activation of the LGK
promoter by SREBP-1c. To localize SREBP-1c binding sites in
the LGK promoter, a DNase I footprinting assay was performed
using a recombinant human SREBP-1 protein (17). As shown
in Fig. 2B, the region from 210 to 167 of the LGK promoter
was protected from DNase I digestion by SREBP-1 protein,
which suggested the binding of SREBP-1 to this region. How-
ever, the protected region was wider than expected, and se-
quence analysis revealed the presence of two SRE consensus
sequences (YCAYNYCAY) in the 210/167 region. An EMSA
was performed using the probe P-225/-150, which covered the
225/150 region of LGK promoter, to confirm the binding of
SREBP-1 to the region. Fig. 2C shows two shifted bands by
SREBP-1. Because recombinant SREBP-1 protein was used in
EMSA, these results suggested that two distinct and closely
located SREBP-1 binding sites exist in the 210/167 region.
Identification of Two Distinct SREs in the LGK Promoter—We
designated two putative SREs as SREa and SREb, respectively,
and produced probes P-216/-187 and P-188/-159, which contained
SREa and SREb, respectively (Fig. 3A). An EMSA using P-216/-
187 and P-188/-159 probes showed the binding of SREBP-1 to
each SRE (Fig. 3B). But SREBP-1 could not bind to mutant
probes P-216/-187ma and P-188/-159mb, which had mutations in
SREa and SREb, respectively. In addition, we observed that the
intensity of the shifted band of P-216/-187 was stronger than that
of P-188/-159. To test the specificity of SREBP-1 binding, we
performed competition assay and supershift assay using P-216/-
187 (Fig. 3C). We employed P-216/-187, P-188/-159, P-216/-
187ma, and P-188/-159mb as unlabeled competitors. An unla-
beled self-competitor, P-216/-187, could completely compete the
binding of SREBP-1 to the probe P-216/-187 (Fig. 3C, lanes 3 and
4). However, unlabeled P-188/-159 competed the probe P-216/-
187 less efficiently than did the self-competitor (Fig. 3C, lanes 5
and 6). SRE-mutated P-216/-187ma and P-188/-159mb did not
compete the probe (Fig. 3C, lanes 7–10). In addition, the anti-
SREBP-1 antibody completely blocked the binding of SREBP-1 to
the probe (Fig. 3C, lane 12). We also performed the same exper-
iment using P-188/-159 to confirm the specificity of SREBP-1
binding to SREb (data not shown). From these results, it was
concluded that SREBP-1 could bind to both SREa and SREb and
that the binding affinity of SREa was stronger than that of SREb.
To know the functional property of the two SREs, we con-
structed mutant version of promoter-luciferase reporter con-
structs and observed the response to SREBP-1c (Fig. 4A). The
internal deletion of the 210/167 region from the LGK pro-
moter (pRGL-1448ab) resulted in the complete loss of activa-
tion by SREBP-1c. Based on an EMSA experiment, we intro-
duced mutations of two nucleotides into SREa and/or SREb
FIG. 1. SREBP-1c activates LGK promoter. Luciferase reporter
constructs under the control of the LGK promoter spanning 1448 to
127, pRGL-1448, and the control pGL3basic vector were transfected
into Alexander cells. Expression plasmids of SREBP-1c (black bars) or
SREBP-2 (gray bars) or the control plasmid pcDNA3 (white bars) was
cotransfected with the reporter. Normalized luciferase activities were
expressed as fold increase relative to the basal activity in the absence of
the SREBP-1c expression vector and represented mean values  S.D.
from three independent experiments.
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named pRGL-1448ma, pRGL-1448mb, and pRGL-1448mab, re-
spectively. Mutations of SREa (pRGL-1448ma) resulted in 80%
loss of SREBP-1c-dependent activation, and mutations of SREb
(pRGL-1448mb) resulted in a 70% loss of activation. SREBP-1c
could not activate the promoter-containing double mutations of
SREa and SREb (pRGL-1448mab). These results indicated that
the two functional SREs were closely related and necessary for
the complete activation of the LGK promoter by SREBP-1c. To
know whether the binding of SREBP-1 to one SRE could affect
the binding to the other SRE, we performed EMSA using the
probe covering the225/150 region of the LGK promoter. We
FIG. 3. Identification of two distinct SREs in the LGK pro-
moter. A, DNA sequences of the wild type and mutant versions of the
putative SREa and SREb are shown. B, EMSAs using the 216/187
and 188/159 regions of the LGK promoter and their mutant probes
were performed. A 32P-labeled probe was incubated with increasing
amounts (50 and 100 ng) of recombinant SREBP-1 as indicated. Only
one shifted band by SREBP-1 was shown. C, EMSA using P-216/-187
was performed to confirm the specificity of SREBP-1 binding. 32P-
labeled probe was incubated with 100 ng of recombinant SREBP-1 as
noted above the respective lanes. Increasing amounts (50- and 100-
molar excess) of unlabeled double strand oligonucleotides were added to
the reaction mixture as indicated. An Anti-SREBP-1 serum was also
added into reaction mixture as indicated.
FIG. 2. Localization of SRE in the LGK promoter. A, 5 serial
deletion constructs of the LGK promoter luciferase reporter were trans-
fected into Alexander cells with (black bars) or without (white bars)
expression of SREBP-1c. 5-ends of the promoters were shown. Normal-
ized luciferase activities were expressed as fold increase relative to the
basal activity in the absence of the SREBP-1c expression vectors and
represented mean values  S.D. from three independent experiments.
B, DNase I footprinting assay was performed to localize SREBP-1
binding sites in the region between 238/-161 of the LGK gene. The
DNA fragment from 320 to 69 of the LGK promoter was labeled by
32P and mixed with recombinant SREBP-1 at protein concentrations
(g) noted above the respective lane. The lane GA contains designated
Maxam-Gilbert sequencing reaction products of the probe DNA. The
regions protected from DNase I digestion were indicated by the box, and
DNA sequences are shown. Two putative SREs are underlined. C, an
EMSA using the225/150 region of the LGK promoter as a probe was
performed. 32P-labeled probe was incubated with recombinant
SREBP-1 at the protein concentrations (ng) noted above the respective
lanes. The shifted bands by SREBP-1 were indicated.
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used the P-225/-150, P-225/-150ma, P-225/-150mb, and P-225/-
150mab as probes (Fig. 4B). Fig. 4C showed the change of the
SREBP-1 binding pattern as a result of the mutations of SREs.
The wild type probe, P-225/-150, showed two shifted bands of
which the upper band was a DNA-protein complex containing
two molecules of SREBP-1, whereas the lower band suggested
one molecule of SREBP-1 binding. When SREa or SREb was
mutated, the intensity of the lower band was moderately de-
creased, whereas the upper band almost disappeared. The
binding of SREBP-1 to P-225/-150mb was stronger than that to
P-225/-150ma. Double mutations in SREa and SREb resulted
in a complete loss of SREBP-1 binding. These results suggested
that SREBP-1 could bind to both SREa and SREb and that the
bindings to these SREs were independent.
High Carbohydrate Diet Increased the Binding of SREBP-1c
on LGK Promoter in Liver—In the liver the expression of LGK
and SREBP-1c were known to be changed by nutritional status.
Thus, we performed a ChIP assay to confirm the functionality
of SREs in vivo and to determine whether the binding of
SREBP-1c to the LGK promoter could be changed by nutri-
tional status. As shown in Fig. 5A, a high carbohydrate diet
dramatically increased the transcription of the GK and
SREBP-1 in rat liver, but SREBP-2 transcription was not
changed by nutritional status. In this state we performed a
ChIP assay to find out whether a high carbohydrate diet could
increase the binding of SREBP-1 on the LGK promoter. As
shown in Fig. 5B, a high carbohydrate diet increased the bind-
ing of SREBP-1 to the 221/169 region of the LGK promoter
containing SREa and SREb. These results indicated that SREa
and SREb were functional SREBP-1c binding sites in vivo and
that a high carbohydrate diet increased SREBP-1 expression,
thereby activating LGK expression in the liver.
FIG. 4. Functional characterization
of SREs. A, wild type or mutant LGK
promoter luciferase reporter constructs
were transfected into Alexander cells
with (black bars) or without (white bars)
overexpression of SREBP-1c. SREa and
SREb are indicated by circles and
squares, respectively, and mutations in
SRE are indicated by . The truncated
region in the promoter is also indicated.
Normalized luciferase activities are ex-
pressed as the fold increase relative to the
basal activity in the absence of the
SREBP-1c expression vector and repre-
sent mean values  S.D. from three inde-
pendent experiments. B, structure of the
P-225/-150 and its mutants of the puta-
tive SREa and SREb are shown. DNA se-
quences of 210/171 is shown, and mu-
tations are indicated by underlining. C,
EMSA using P-225/-150 and its mutants
were performed. 32P-labeled probes were
incubated with 100 ng of recombinant
SREBP-1. The shifted bands by SREBP-1
are indicated.
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SREBP-1c Mediated the Transcriptional Activation of LGK
by Insulin—It was reported that insulin regulates LGK gene
expression and SREBP-1c mediates the action of insulin on
LGK gene expression (23, 24). To determine whether insulin
could activate the LGK promoter, we transfected LGK pro-
moter luciferase reporter constructs into Alexander cells in the
presence or absence of insulin. As shown in Fig. 6A, insulin
increased the LGK promoter activity by 2.5-fold. However in-
sulin did not activate the promoters lacking the SREs (pRGL-
1448ab and pRGL-161). These results suggested that SREa
and SREb might be responsible for the insulin-dependent ac-
tivation of the LGK promoter. Thus, we isolated primary hepa-
tocytes from the liver of normal Sprague-Dawley rats and
treated them with insulin to delineate the relationship between
insulin, SREBP-1c, and GK. Fig. 6B shows the transcription of
LGK and SREBP-1. Insulin selectively stimulated the tran-
scription of LGK and SREBP-1c without changing the expres-
sion of SREBP-1a. A ChIP assay using the primary hepatocytes
cultured in the presence or absence of insulin revealed that the
binding of SREBP-1c to the 221/169 region of the LGK
promoter was increased by insulin (Fig. 6C). Despite these
results, it is still possible that SREBP-1c may indirectly par-
ticipate in the insulin-dependent activation of LGK. To find out
whether SREBP-1c may directly mediate insulin-dependent
LGK expression, we transduced an adenovirus containing
SREBP-1c or SREBP-1cDN into the primary hepatocytes in the
presence or absence of insulin. As shown in Fig. 6D, LGK
expression is increased by adenoviral expression of SREBP-1c
in the absence of insulin, which is blocked by SREBP-1cDN. In
addition, adenoviral expression of SREBP-1cDN could block
the insulin-dependent stimulation of LGK gene expression.
These results strongly suggested that SREa and SREb are
responsible for the SREBP-1c-mediated activation of LGK gene
expression by insulin.
DISCUSSION
Recently, SREBP-1c has been suggested to mediate the in-
sulin action on hepatic GK transcription. SREBP-1c expression
FIG. 5. High carbohydrate diet increased the binding of
SREBP-1c on LGK promoter. Rats fasted for 24 h and were fed fat-free
high carbohydrates for 24 h. Then the rats were sacrificed, and livers were
removed at the 0- and 24-h time points. A, Northern blot analysis was
performed to confirm the changes of the transcriptions of GK, SREBP-1,
and SREBP-2. Total RNA (20 g) isolated from the livers of each group
was subjected to 1% formaldehyde agarose gel electrophoresis. RNA in the
gel was transferred to a nylon membrane and hybridized to 32P-labeled
cDNAs for GK, SREBP-1, or SREBP-2. B, the association of SREBPs and
the LGK promoter in rat liver was measured by ChIP assay. Livers of
fasted (F) or refed (R) rats were cross-linked using formaldehyde. Chro-
matins of each group were incubated with anti-SREBP antiserum. DNAs
in the presence or in the absence of antiserum were immunoprecipitated,
and PCR amplification of the DNA fragments was conducted using primer
pairs specific to the 320/151 region of LGK. To confirm the same
amounts of chromatins used in immunoprecipitation between groups,
input chromatin was also used.
FIG. 6. Insulin increased the binding of SREBP-1c on LGK
promoter. A, wild type or mutant LGK promoter luciferase reporter
constructs were transfected into Alexander cells with (black bars) or
without (white bars) insulin treatment (100 nM). B, primary hepato-
cytes isolated from rats were incubated in the presence or absence of
insulin (100 nM). Semiquantitative analysis of LGK, SREBP-1a, and
SREBP-1c was performed by reverse transcription PCR. C, a ChIP
assay was adopted to measure the change of the binding of the SREBPs
to SREs in response to insulin. Primary hepatocytes were incubated in
the presence or absence of insulin for 12 h and cross-linked using
formaldehyde. Chromatins of each group were incubated with anti-
SREBP antiserum. DNA in the presence or absence of antiserum was
immunoprecipitated, and PCR amplification of the DNA fragments was
performed using primer pairs specific to the 320/151 region of LGK.
To confirm the same amounts of chromatins used in immunoprecipita-
tion between groups, input chromatin was also used. D, adenovirus
containing SREBP-1c or SREBP-1cDN or a null adenovirus was trans-
duced into primary hepatocytes isolated from rats. The cells were then
incubated in the presence or absence of insulin (100 nM) for 24 h.
Semiquantitative analysis of LGK was performed by reverse transcrip-
tion PCR. The quantity of the mRNAs was normalized with respect to
-actin mRNA.
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is decreased in liver during fasting, which suppresses insulin
and increases glucagon levels and is increased by refeeding (15,
25, 26). The expression of lipogenic genes are not increased by
high-carbohydrate diet in SREBP-1 knock-out mice (27).
SREBP-1c expression is very low in the liver of streptozotocin-
induced diabetic rats and markedly increased by insulin (23).
Adenoviral expression of SREBP-1c in the liver of streptozoto-
cin-induced diabetic mice increased lipogenic gene expression,
mimicking the effects of insulin (28). Overexpression of the
dominant negative mutant of SREBP-1c blocked the insulin-
dependent activation of GK and lipogenic gene expression in
the liver (24, 28). In isolated rat hepatocytes, insulin treatment
increased the amount of mRNA for SREBP-1c in parallel with
the mRNAs of lipogenic genes, and glucagons can antagonize
insulin action (23, 24, 26). Induction of lipogenic genes can be
blocked if a dominant negative form of SREBP-1c is expressed
(26). In addition, SRE has been identified in many promoters of
lipogenic genes such as fatty acid synthase, acetyl-CoA carbox-
ylase, ATP citrate-lyase, and S14, and insulin-responsive re-
gions of fatty acid synthase and S14 genes are colocalized with
functional SREBP-1c binding sites (17, 29–33). However, nei-
ther the insulin-responsive region nor the SREBP response
element has been identified in the LGK promoter.
In the present study, we identified two functional SREBP-1c
response elements, SREa and SREb, in the rat LGK promoter.
SREBP-1c binds to these SREs and activates the LGK promoter.
In an EMSA, the binding of SREBP-1 to SREa or SREb was not
mutually exclusive. SREa showed a stronger affinity to SREBP-1
compared with SREb. However, these in vitro binding assay data
were not in parallel with the transfection assay. Transient trans-
fection assay showed that both SREa and SREb were necessary
for the transactivation of LGK promoter by SREBP-1c, and the
physical interaction between the protein and SREs of the LGK
promoter in vivo was confirmed by ChIP assay. A high carbohy-
drate diet increased the expression of SREBP-1 and GK in rat
liver and the binding of SREBP-1 to the LGK promoter. Given
that SREBP-1c was a major form of SREBP-1 and that the
expression of SREBP-1c was known to be regulated by insulin in
liver, the increased GK expression by high carbohydrate feeding
might be due to the increased binding of SREBP-1c to the LGK
promoter. We also showed evidence supporting this hypothesis
using primary hepatocytes. Insulin selectively increased
SREBP-1c and LGK expression in primary cultured hepatocytes,
which was blocked by adenoviral expression of the dominant
negative mutant of SREBP-1c. A ChIP assay using primary
hepatocytes showed the increased binding of SREBP-1 to SREs of
LGK promoter. From these results, we could conclude that the
binding of SREBP-1c to SREa and SREb is responsible for insulin-
dependent LGK expression.
In this study, it was not possible to explain the detailed
relationship between SREa and SREb in SREBP-1c-mediated
activation of LGK by insulin. There may be some unknown or
additional mediators that play important roles in SRE-medi-
ated transactivation of the LGK gene. We thought that there
might be something more than SREBP-1c linking SREa and
SREb in the regulation of LGK promoter by SREBP-1c. When
pRGL-1448 was transfected into Alexander cells or primary
hepatocytes, the promoter showed only 2.5-fold activation by
insulin, which is much smaller than the activation of LGK
promoter by SREBP-1c. This marginal activation suggested
that other regions outside the 1448/127 region or other
factors that are lacking in these experimental conditions might
involve the increase of SREBP-1c binding to SREa and SREb
by insulin in vivo.
In conclusion, we identified functional SREs in the rat LGK
promoter and demonstrated that SREBP-1c is the transcrip-
tion factor mediating insulin action on LGK expression. Al-
though the mutual interaction of these two cis-elements in
activating LGK gene expression remains elusive, the tandem
array of SREa and SREb may provide a fine control for regu-
lating glucose homeostasis by LGK.
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Vol. 278 (2003) 50702–50713
Temporal and spatial modulation of Rho GTPases during in vitro formation of capillary vascular network.
Adherens junctions and myosin light chain as targets of Rac1 and RhoA.
Ilaria Cascone, Enrico Giraudo, Francesca Caccavari, Lucia Napione, Elisa Bertotti, John G. Collard, Guido Serini, and
Federico Bussolino
Page 50711: Fig. 9D was inadvertently omitted. The figure and legend are shown on facing page.
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FIG. 9. Effect of the expression of N17Rac1 on the dynamic of cell-to-cell adherens junctions. A, capillary ECs carrying vector alone
or N17Rac1 were plated on Matrigel and dispersed with MatriSperse cell recovery solution at 30 min or at 2 h from the beginning of the
morphogenetic process, lysed, and immunoprecipitated (IP) with mAb anti--catenin. Proteins were separated by SDS-PAGE (8%) and then
immunoblotted with Abs anti-IQGAP-1 and anti--catenin and mAbs anti-Ve-cadherin and anti--catenin. The total amounts in vector-ECs of the
indicated proteins are shown in the 1st lane. Equal results have been obtained in N17Rac1-ECs (not shown). B, ECs carrying vector alone or
N17Rac1 were recovered as indicated above and lysed. After centrifugation, Triton X-100-insoluble pellets were solubilized in SDS buffer detailed
under “Experimental Procedures” and boiled for 5 min. Solubilized proteins were separated on SDS-PAGE 8%) and immunoblotted with mAbs
anti-Ve-cadherin or anti--catenin. Densitometric analysis of three independent experiments is shown as mean  S.D. C, ECs carrying N17Rac1
were plated on Matrigel and after 2 h fixed and stained with TRICT-phalloidin (a). b shows the GFP expression in one of the two cells recorded
in a. The negative GFP cell, which does not express N17Rac1, shows actin cable near and perpendicular to the cell protrusion forming the contact
with a GFP-, N17Rac1-expressing cell. In this cell, F-actin is absent at the protrusion cone. Four experiments with similar results were performed.
D, confluent cultured ECs carrying vector alone (a) or N17Rac1 (b) were treated with 0.01% trypsin in Hepes-buffered (TC treatment) or in
Hepes-buffered saline without Ca2 supplemented with 1 mM EGTA (TE treatment) for 15 min at 37 °C and dissociated through 10 times pipetting.
The extent of dissociation cells was represented by the index NTC/NTE, where NTC and NTE are the number of clusters and single cells, respectively.
This figure is representative of three experiments obtained with similar results.
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Single nucleotide polymorphism (468 Gly to Ala) at the promoter region of sterol regulatory element-binding
protein-1c associates with genetic defect of fructose-induced hepatic lipogenesis.
Ryoko Nagata, Yoshihiko Nishio, Osamu Sekine, Yoshio Nagai, Yasuhiro Maeno, Satoshi Ugi, Hiroshi Maegawa, and Atsunori
Kashiwagi
The title was incorrect. The correct title should be:
Single nucleotide polymorphism (468 G to A) at the promoter region of SREBP-1c associates with genetic defect of fructose-
induced hepatic lipogenesis
Vol. 279 (2004) 30823–30829
SREBP-1c mediates the insulin-dependent hepatic glucokinase expression.
So-Youn Kim, Ha-il Kim, Tae-Hyun Kim, Seung-Soon Im, Sang-Kyu Park, In-Kyu Lee, Kyung-Sup Kim, and Yong-Ho Ahn
Page 30827, Fig. 4B: In Fig. 4B, the sequence of oligonucleotide P-225/-150 is shown in the top line, and SREa and SREb are
marked by underlines. The lower three lines are mutated oligonucleotides. There is a mistake in the second line, which indicates
the oligonucleotide-containing mutation of SREa. The sequence of P-225/-150ma is equal to P-225/-150mab. “TT” of the SREb
position should be changed by – –. The corrected figure is shown below.
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